查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2014860

膝關節移植市場：2026-2032年全球市場預測（以固定方式、材料、設計、技術、病患年齡層、限制等級、最終用戶和通路分類）

Knee Implant Market by Fixation Method, Material, Design, Technology, Patient Age Group, Constraint Level, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，膝關節移植市場價值將達到 34.4 億美元，到 2026 年將成長至 37.2 億美元，到 2032 年將達到 59.8 億美元，複合年成長率為 8.22%。

主要市場統計數據
基準年 2025 34.4億美元
預計年份：2026年 37.2億美元
預測年份：2032年 59.8億美元
複合年成長率 (%) 8.22%

對現代膝關節移植現狀進行簡要概述，重點關注臨床挑戰、手術流程、監管壓力和商業策略重點。

由於人口老化、臨床需求變化以及技術的快速創新，膝關節移植產業正處於轉型期。本執行摘要整合了關鍵趨勢、結構性變化以及臨床、商業和投資領域相關人員的實用切入點。它並非羅列現狀，而是從臨床需求、器材創新、醫療服務模式和監管壓力等角度梳理當前環境，從而為制定有針對性的策略規劃提供支援。

快速的技術進步和醫療保健服務模式的轉變正在重新定義膝關節移植的整個生態系統，從採用和採購到臨床價值提案。

膝關節移植市場正經歷著變革性的轉變，這些轉變正在重塑競爭動態和臨床應用管道。包括電腦導航和機器人輔助平台在內的外科輔助技術的創新，正在改變外科醫生的技能要求，並改變醫院和門診手術中心的資金配置模式。隨著醫院評估投資，採購決策越來越重視的不僅是價格，還有工作流程整合、互通性以及植入的終身價值。

政策主導的關稅壓力正在促使整個膝關節移植價值鏈進行供應鏈重組、加速近岸外包和策略定價。

美國近期推出的關稅措施進一步加劇了全球供應商、經銷商以及依賴區域性製造策略的商業性複雜性。擁有大規模跨境供應鏈的製造商正在重新審視其採購地點和供應商契約，以降低不斷上漲的進口成本。為此，許多公司正在加快近岸外包的步伐，並重新談判長期採購契約，力求在確保產品供應穩定和品質標準的同時，維持利潤率。

對產品、手術技術、固定方法、材料、設計、技術、最終用戶、分銷管道、年齡層和限制水平進行詳細的細分映射，有助於制定有針對性的策略規劃。

細分市場分析能夠提供深入的觀點，幫助識別臨床需求、商業化路徑和投資重點。按產品類型分類，植入組合涵蓋部分膝關節關節重建、膝蓋大腿關節置換術、重新置換膝關節置換和全關節重建，每種類型都有其獨特的適應症、患者選擇標準和外科醫生熟練度曲線。手術細分則區分部分置換術、初次置換術和重新置換，這決定了臨床證據需求、報銷代碼和後續護理模式。

區域趨勢揭示了美洲、歐洲、中東、非洲和亞太市場在部署模式、監管複雜性和基礎設施主導的部署管道方面的差異。

區域趨勢塑造全球需求模式、新技術應用速度和競爭格局。在美洲，完善的醫保報銷管道、高手術率手術中心的集中網路以及人口老化，共同推動初次手術和重新置換手術的持續需求。同時，私立醫院和門診手術中心作為微創和機器人手術平台的早期採用者，發揮關鍵作用。跨境製造和貿易關係也影響區域庫存策略和經銷夥伴。

競爭格局由一體化供應鏈、證據產生、通路策略和卓越服務所塑造，從而促進產品採用和長期忠誠度。

競爭動態由專有技術、實證能力和通路關係之間的相互作用決定。主要企業受益於垂直整合的供應鏈、強大的臨床數據項目以及與外科領域意見領袖的深厚關係，而敏捷的新興企業則透過材料和植入設計的精準創新，開闢利基市場。平台提供者和植入製造商之間的策略合作日益普遍，將軟體驅動的手術系統與互補的植入產品線相結合，以實現一致的臨床工作流程。

我們優先考慮綜合證據產生、穩健的供應模式和以價值為導向的商業策略，以實現臨床療效和永續的市場成長。

產業領導者應優先考慮採取平衡策略，以應對臨床療效、供應鏈韌性和商業性靈活性等問題。投資於涵蓋療效比較、長期生存率和患者報告結果等可靠證據的收集，將有助於加快外科醫生和保險公司的接受度；而模組化生產和多元化採購則有助於降低貿易政策波動帶來的風險。機器人輔助和電腦導航平台的戰術性部署應輔以結構化的培訓計劃和經濟模型，以明確手術效率和高品質療效的投資回報。

結合與關鍵相關人員的訪談、二次臨床和監管分析以及多情境檢驗，採用穩健的調查方法，為策略決策提供支援。

本研究途徑整合了多種調查方法，以確保研究的嚴謹性、可重複性和對決策者的相關性。主要定性資料透過對骨科醫生、採購經理和醫療設備工程師的結構化訪談獲得，以了解他們對器械性能、手術流程影響和採購標準的實際觀點。次要分析則利用同行評審的臨床文獻、監管申報文件和公共採購記錄來檢驗臨床結果並追蹤應用趨勢，同時，產業財務資訊披露和投資者報告提供有關資本配置和策略重點的背景資訊。

我們整合了強調臨床有效性、營運韌性和適應性商業性方法的策略挑戰，以確保長期競爭優勢。

綜上所述，這些研究結果表明，膝關節移植領域的成功取決於一項整合策略，該策略融合了卓越的臨床技術、柔軟性的營運模式和精準的商業性定位。材料、植入設計和手術輔助技術的進步為改善患者預後和產品系列差異化創造了機遇，但嚴謹的證據和有效的培訓對於大規模應用這些進步至關重要。同樣，鑑於不斷變化的貿易政策和多元化的支付方環境，供應鏈的韌性和明確的區域策略也同樣重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：膝關節移植市場：以固定方式分類

  • 水泥固定型
  • 無水泥型
  • 混合

第9章：膝關節移植市場：依材料分類

  • 陶瓷與塑膠
  • 金屬與金屬
  • 金屬與塑膠

第10章：膝關節移植市場：依設計分類

  • 十字韌帶保留型
    • 向內旋轉
    • 標準
  • 固定軸承
  • 活動軸承
  • 後穩定型

第11章：膝關節移植市場：依技術分類

  • 電腦導航類型
  • 傳統的
  • 機器人輔助
    • 全自動
    • 半自動

第12章：膝關節移植市場：依患者年齡層分類

  • 成年人（18-64歲）
  • 老年人（65歲以上）
  • 兒童（18歲以下）

第13章：膝關節移植市場：依限制層級分類

  • 抑制類型
  • 半抑制型
  • 不受限制的類型

第14章：膝關節移植市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 大學醫院
    • 私立醫院
  • 整形外科診所

第15章：膝關節移植市場：依通路分類

  • 直銷
  • 銷售代理
    • 獨家銷售
    • 非獨家銷售
  • 線上管道

第16章：膝關節移植市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第17章膝關節移植市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第18章：膝關節移植市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第19章：美國膝關節移植市場

第20章：中國膝關節移植市場

第21章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • ConforMIS, Inc.
  • Corin Group plc
  • DePuy Synthes, Inc.
  • Exactech, Inc.
  • LimaCorporate SpA
  • MicroPort Scientific Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-43470FC60846

The Knee Implant Market was valued at USD 3.44 billion in 2025 and is projected to grow to USD 3.72 billion in 2026, with a CAGR of 8.22%, reaching USD 5.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.44 billion
Estimated Year [2026] USD 3.72 billion
Forecast Year [2032] USD 5.98 billion
CAGR (%) 8.22%

Concise orientation to the contemporary knee implant environment highlighting clinical imperatives, surgical workflows, regulatory pressures, and commercial strategic priorities

The knee implant landscape is at an inflection point driven by aging demographics, evolving clinical expectations, and rapid technological change. This executive summary synthesizes core trends, structural shifts, and actionable entry points for stakeholders across clinical, commercial, and investment communities. It frames the current environment in terms of clinical needs, device innovation, provider delivery models, and regulatory pressures to enable focused strategic planning rather than a broad descriptive inventory.

Drawing from multidisciplinary inputs and peer-reviewed clinical literature, the analysis foregrounds how patient outcomes, surgical workflows, and reimbursement dynamics interact. The intent is to provide decision-makers with a concise but nuanced orientation that highlights risk vectors and growth levers. Throughout the report, emphasis is placed on translating clinical evidence and operational realities into high-impact strategic priorities, emphasizing where incremental improvements in device design, process automation, or service delivery can create measurable differentiation.

Rapid technological advances and changing care delivery models are redefining adoption, procurement, and clinical value propositions across the knee implant ecosystem

The knee implant market is experiencing transformative shifts that are reshaping competitive dynamics and clinical adoption pathways. Innovations in surgical assistance, including computer navigated and robotic assisted platforms, are altering the skill requirements for surgeons and changing capital allocation patterns within hospitals and ambulatory surgical centers. As hospitals evaluate investments, procurement decisions increasingly incorporate workflow integration, interoperability, and lifetime value of implants rather than price alone.

Simultaneously, implant design evolution-ranging from advances in bearing configurations to material science improvements-has reduced revision rates and improved kinematic fidelity for diverse patient cohorts. These technological and design advances are complemented by shifting care delivery models: outpatient arthroplasty volumes are rising, and orthopedics is seeing greater diffusion of procedures into ambulatory surgical centers and specialty clinics. Regulatory scrutiny and post-market surveillance have intensified, prompting manufacturers to invest in evidence generation and longer-term outcome tracking to sustain adoption and address payer concerns.

Policy-driven tariff pressures are prompting supply chain reconfiguration, accelerated nearshoring, and strategic pricing responses across the knee implant value chain

Recent tariff policies originating from the United States have introduced a layer of commercial complexity for global suppliers, distributors, and regionally dependent manufacturing strategies. Manufacturers with significant cross-border supply chains are reassessing sourcing footprints and supplier contracts to mitigate increased landed costs. In response, several firms are accelerating nearshoring initiatives or renegotiating long-term procurement agreements to preserve margin while maintaining device availability and quality standards.

Beyond immediate cost implications, tariffs influence strategic decisions around product localization, regulatory filings, and market prioritization. Firms with modular manufacturing capabilities and diversified component sourcing are better positioned to absorb tariff shocks without disrupting clinical supply. Meanwhile, downstream stakeholders, including hospitals and ambulatory surgical centers, may experience shifts in pricing negotiation dynamics as providers seek transparency on implant cost drivers. Over time, these policy-driven pressures will favor companies that can demonstrate resilient supply networks, flexible manufacturing, and clear total-cost-of-care value propositions.

Detailed segmentation mapping of products, procedures, fixation methods, materials, designs, technologies, end users, channels, age cohorts, and constraint levels to inform targeted strategies

Segmentation analysis provides a granular lens for identifying clinical demand, commercialization pathways, and investment priorities. By product type, implant portfolios span Partial Knee Replacement, Patellofemoral Replacement, Revision Knee Replacement, and Total Knee Replacement, each representing distinct indications, patient selection criteria, and surgeon familiarity curves. Procedure segmentation differentiates Partial Replacement, Primary Replacement, and Revision Replacement, which in turn drives clinical evidence needs, reimbursement coding, and follow-up care models.

Fixation method segmentation encompasses Cemented, Cementless, and Hybrid approaches, with each method linked to surgical technique, patient bone quality considerations, and long-term survivorship data imperatives. Material choices-Ceramic On Plastic, Metal On Metal, and Metal On Plastic-introduce trade-offs around wear characteristics, biocompatibility, and regulatory scrutiny, shaping clinical adoption and post-market monitoring. Design segmentation, which includes Cruciate Retaining, Fixed Bearing, Mobile Bearing, and Posterior Stabilized configurations, further refines clinical matching; within Cruciate Retaining, distinctions between Medial Rotation and Standard variants affect kinematic outcomes and surgeon preference.

Technology segmentation contrasts Computer Navigated, Conventional, and Robotic Assisted platforms, with Robotic Assisted options bifurcated into Fully Automated and Semi-Automated systems that differ in capital intensity, learning curve demands, and evidence generation pathways. End user segmentation captures Ambulatory Surgical Centers, Hospitals, and Orthopedic Clinics, noting that Hospitals subdivide into Academic and Private institutions with divergent procurement processes and clinical trial linkages. Distribution channels include Direct Sales, Distributors, and Online Channels, where Distributors may operate under Exclusive or Nonexclusive agreements influencing market access and pricing leverage. Patient Age Group segmentation distinguishes Adult (18-64), Geriatric (65 And Above), and Pediatric (<18) cohorts, each with specific functional outcome expectations and comorbidity profiles. Finally, Constraint Level segmentation across Constrained, Semiconstrained, and Unconstrained implants affects device selection for complex anatomies and revision scenarios.

Taken together, these segmentation axes enable precise portfolio optimization, targeted clinical trials, and differentiated go-to-market strategies that align product features with provider and patient needs.

Regional dynamics reveal differentiated adoption patterns, regulatory complexities, and infrastructure-driven trajectories across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics are shaping demand patterns, adoption velocity of novel technologies, and competitive positioning across the globe. In the Americas, the combination of established reimbursement pathways, a concentrated network of high-volume surgical centers, and an aging population fuels sustained demand for both primary and revision procedures, while private hospitals and ambulatory surgical centers serve as critical early adopters for minimally invasive and robotic platforms. Cross-border manufacturing and trade relationships also influence inventory strategies and distribution partnerships within the region.

The Europe, Middle East & Africa region presents heterogeneous regulatory environments and diverse payer systems; academic centers and national health services often drive evidence requirements and purchasing protocols, while private hospitals and specialty clinics can accelerate uptake of premium implants and advanced technologies through value-based partnerships. Local manufacturing hubs in select countries offer advantages for market access and responsiveness to regulatory expectations. In the Asia-Pacific region, expanding healthcare infrastructure, rising surgical volumes, and increasing investment in robotic and navigation platforms are reshaping competitive dynamics. Emerging middle-income markets are showing rapid growth in elective arthroplasty, accompanied by an expanding network of distributors and localized service offerings, while regulatory maturity varies across jurisdictions and influences entry strategies.

Competitive landscape shaped by integrated supply chains, evidence generation, channel strategy, and service excellence that drive adoption and long-term loyalty

Competitive dynamics are defined by the interplay of proprietary technologies, evidence generation capabilities, and channel relationships. Leading firms benefit from vertically integrated supply chains, robust clinical data programs, and deep relationships with surgical opinion leaders, yet nimble challengers are carving niches through targeted innovation in materials and implant design. Strategic partnerships between platform providers and implant manufacturers are increasingly common, aligning software-enabled surgical systems with complementary implant portfolios to deliver cohesive clinical workflows.

Service excellence in areas such as training, surgeon support, and post-market surveillance is a differentiator that enhances device adoption and loyalty. Companies that invest in longitudinal outcome tracking and real-world evidence generation strengthen payer discussions and clinician confidence. Moreover, distribution strategy-whether via direct sales, exclusive distributors, or hybrid channels-remains a decisive factor in market penetration, particularly in geographies with fragmented provider networks. Alliances with ambulatory surgical centers and specialized orthopedic clinics can accelerate diffusion of less invasive procedures and new implant designs, while academic partnerships continue to underpin the most rigorous clinical validation efforts.

Prioritize integrated evidence generation, resilient supply models, and value-focused commercial strategies to align clinical performance with sustainable market growth

Industry leaders should prioritize a balanced approach that addresses clinical performance, supply resilience, and commercial agility. Investment in robust evidence generation-covering comparative effectiveness, long-term survivorship, and patient-reported outcomes-will fast-track acceptance among surgeons and payers, while modular manufacturing and diversified sourcing reduce vulnerability to trade policy fluctuations. Tactical deployment of robotic assisted and computer navigated platforms should be accompanied by structured training programs and economic models that clarify return on surgical efficiency and quality outcomes.

Commercial strategies should emphasize value-based conversations with providers, demonstrating how implant choices and surgical platforms affect total cost of care rather than focusing solely on unit price. For firms expanding into new regions, localized regulatory strategy, selective distributor partnerships, and tailored reimbursement engagement are essential. Additionally, investing in digital tools for patient education, remote monitoring, and outcome tracking can differentiate offerings and support bundled payment initiatives. Finally, scenario planning for policy shocks, such as tariff changes, will preserve optionality and enable rapid tactical shifts without disrupting clinical supply or market momentum.

A robust research methodology combining primary stakeholder interviews, secondary clinical and regulatory analysis, and multi-scenario validation to support strategic decisions

The research approach integrates multiple methodologies to ensure rigor, reproducibility, and relevance to decision-makers. Primary qualitative inputs include structured interviews with orthopedic surgeons, procurement leaders, and device engineers to capture frontline perspectives on device performance, surgical workflow impacts, and purchasing criteria. Secondary analysis draws on peer-reviewed clinical literature, regulatory filings, and public procurement records to validate clinical outcomes and map adoption trajectories, while industry financial disclosures and investor presentations provide context on capital allocation and strategic priorities.

Analytical techniques applied include comparative device feature mapping, scenario analysis for supply chain disruptions, and triangulation of qualitative insights with published evidence to identify consensus and areas of ongoing debate. The methodology emphasizes transparency in assumptions and source attribution, facilitating replication and targeted follow-ups. Where appropriate, sensitivity checks were performed to test conclusions across varying clinical and policy conditions, ensuring that strategic recommendations are robust under plausible future states.

Synthesize strategic imperatives emphasizing clinical validation, operational resilience, and adaptive commercial approaches to secure long-term competitive advantage

The cumulative findings underscore that success in the knee implant arena depends on an integrated strategy that combines clinical excellence, operational flexibility, and astute commercial positioning. Advances in materials, implant design, and surgical assistance technologies are creating opportunities to improve patient outcomes and differentiate product portfolios, but these advances must be supported by rigorous evidence and effective training to achieve scale. Supply chain resilience and thoughtful regional strategies are equally important given evolving trade policies and diverse payer environments.

As stakeholders evaluate next steps, they should weigh near-term operational improvements against longer-term investments in clinical data and platform development. Organizations that align product development with demonstrable patient and provider benefits, while preserving agility to respond to policy or market shifts, will be best positioned to capture durable value. Continuous monitoring of clinical outcomes, regulatory trends, and provider preferences will enable iterative refinement of strategies and support sustained competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Knee Implant Market, by Fixation Method

  • 8.1. Cemented
  • 8.2. Cementless
  • 8.3. Hybrid

9. Knee Implant Market, by Material

  • 9.1. Ceramic On Plastic
  • 9.2. Metal On Metal
  • 9.3. Metal On Plastic

10. Knee Implant Market, by Design

  • 10.1. Cruciate Retaining
    • 10.1.1. Medial Rotation
    • 10.1.2. Standard
  • 10.2. Fixed Bearing
  • 10.3. Mobile Bearing
  • 10.4. Posterior Stabilized

11. Knee Implant Market, by Technology

  • 11.1. Computer Navigated
  • 11.2. Conventional
  • 11.3. Robotic Assisted
    • 11.3.1. Fully Automated
    • 11.3.2. Semi-Automated

12. Knee Implant Market, by Patient Age Group

  • 12.1. Adult (18-64)
  • 12.2. Geriatric (65 And Above)
  • 12.3. Pediatric (<18)

13. Knee Implant Market, by Constraint Level

  • 13.1. Constrained
  • 13.2. Semiconstrained
  • 13.3. Unconstrained

14. Knee Implant Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Hospitals
    • 14.2.1. Academic
    • 14.2.2. Private
  • 14.3. Orthopedic Clinics

15. Knee Implant Market, by Distribution Channel

  • 15.1. Direct Sales
  • 15.2. Distributors
    • 15.2.1. Exclusive
    • 15.2.2. Nonexclusive
  • 15.3. Online Channels

16. Knee Implant Market, by Region

  • 16.1. Americas
    • 16.1.1. North America
    • 16.1.2. Latin America
  • 16.2. Europe, Middle East & Africa
    • 16.2.1. Europe
    • 16.2.2. Middle East
    • 16.2.3. Africa
  • 16.3. Asia-Pacific

17. Knee Implant Market, by Group

  • 17.1. ASEAN
  • 17.2. GCC
  • 17.3. European Union
  • 17.4. BRICS
  • 17.5. G7
  • 17.6. NATO

18. Knee Implant Market, by Country

  • 18.1. United States
  • 18.2. Canada
  • 18.3. Mexico
  • 18.4. Brazil
  • 18.5. United Kingdom
  • 18.6. Germany
  • 18.7. France
  • 18.8. Russia
  • 18.9. Italy
  • 18.10. Spain
  • 18.11. China
  • 18.12. India
  • 18.13. Japan
  • 18.14. Australia
  • 18.15. South Korea

19. United States Knee Implant Market

20. China Knee Implant Market

21. Competitive Landscape

  • 21.1. Market Concentration Analysis, 2025
    • 21.1.1. Concentration Ratio (CR)
    • 21.1.2. Herfindahl Hirschman Index (HHI)
  • 21.2. Recent Developments & Impact Analysis, 2025
  • 21.3. Product Portfolio Analysis, 2025
  • 21.4. Benchmarking Analysis, 2025
  • 21.5. B. Braun Melsungen AG
  • 21.6. ConforMIS, Inc.
  • 21.7. Corin Group plc
  • 21.8. DePuy Synthes, Inc.
  • 21.9. Exactech, Inc.
  • 21.10. LimaCorporate S.p.A.
  • 21.11. MicroPort Scientific Corporation
  • 21.12. Smith & Nephew plc
  • 21.13. Stryker Corporation
  • 21.14. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL KNEE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL KNEE IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL KNEE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL KNEE IMPLANT MARKET SIZE, BY DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL KNEE IMPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL KNEE IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL KNEE IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. UNITED STATES KNEE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 16. CHINA KNEE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL KNEE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL KNEE IMPLANT MARKET SIZE, BY CEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL KNEE IMPLANT MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL KNEE IMPLANT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL KNEE IMPLANT MARKET SIZE, BY CEMENTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL KNEE IMPLANT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL KNEE IMPLANT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL KNEE IMPLANT MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL KNEE IMPLANT MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL KNEE IMPLANT MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL KNEE IMPLANT MARKET SIZE, BY CERAMIC ON PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL KNEE IMPLANT MARKET SIZE, BY CERAMIC ON PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL KNEE IMPLANT MARKET SIZE, BY CERAMIC ON PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL KNEE IMPLANT MARKET SIZE, BY METAL ON METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL KNEE IMPLANT MARKET SIZE, BY METAL ON METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL KNEE IMPLANT MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL KNEE IMPLANT MARKET SIZE, BY METAL ON PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL KNEE IMPLANT MARKET SIZE, BY METAL ON PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL KNEE IMPLANT MARKET SIZE, BY METAL ON PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL KNEE IMPLANT MARKET SIZE, BY MEDIAL ROTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL KNEE IMPLANT MARKET SIZE, BY MEDIAL ROTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL KNEE IMPLANT MARKET SIZE, BY MEDIAL ROTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL KNEE IMPLANT MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL KNEE IMPLANT MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL KNEE IMPLANT MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL KNEE IMPLANT MARKET SIZE, BY FIXED BEARING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL KNEE IMPLANT MARKET SIZE, BY FIXED BEARING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL KNEE IMPLANT MARKET SIZE, BY FIXED BEARING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL KNEE IMPLANT MARKET SIZE, BY MOBILE BEARING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL KNEE IMPLANT MARKET SIZE, BY MOBILE BEARING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL KNEE IMPLANT MARKET SIZE, BY MOBILE BEARING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL KNEE IMPLANT MARKET SIZE, BY POSTERIOR STABILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL KNEE IMPLANT MARKET SIZE, BY POSTERIOR STABILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL KNEE IMPLANT MARKET SIZE, BY POSTERIOR STABILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL KNEE IMPLANT MARKET SIZE, BY COMPUTER NAVIGATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL KNEE IMPLANT MARKET SIZE, BY COMPUTER NAVIGATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL KNEE IMPLANT MARKET SIZE, BY COMPUTER NAVIGATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL KNEE IMPLANT MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL KNEE IMPLANT MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL KNEE IMPLANT MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL KNEE IMPLANT MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL KNEE IMPLANT MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL KNEE IMPLANT MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL KNEE IMPLANT MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL KNEE IMPLANT MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL KNEE IMPLANT MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL KNEE IMPLANT MARKET SIZE, BY ADULT (18-64), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL KNEE IMPLANT MARKET SIZE, BY ADULT (18-64), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL KNEE IMPLANT MARKET SIZE, BY ADULT (18-64), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL KNEE IMPLANT MARKET SIZE, BY GERIATRIC (65 AND ABOVE), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL KNEE IMPLANT MARKET SIZE, BY GERIATRIC (65 AND ABOVE), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL KNEE IMPLANT MARKET SIZE, BY GERIATRIC (65 AND ABOVE), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL KNEE IMPLANT MARKET SIZE, BY PEDIATRIC (<18), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL KNEE IMPLANT MARKET SIZE, BY PEDIATRIC (<18), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL KNEE IMPLANT MARKET SIZE, BY PEDIATRIC (<18), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL KNEE IMPLANT MARKET SIZE, BY CONSTRAINED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL KNEE IMPLANT MARKET SIZE, BY CONSTRAINED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL KNEE IMPLANT MARKET SIZE, BY CONSTRAINED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL KNEE IMPLANT MARKET SIZE, BY SEMICONSTRAINED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL KNEE IMPLANT MARKET SIZE, BY SEMICONSTRAINED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL KNEE IMPLANT MARKET SIZE, BY SEMICONSTRAINED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL KNEE IMPLANT MARKET SIZE, BY UNCONSTRAINED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL KNEE IMPLANT MARKET SIZE, BY UNCONSTRAINED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL KNEE IMPLANT MARKET SIZE, BY UNCONSTRAINED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL KNEE IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL KNEE IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL KNEE IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL KNEE IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL KNEE IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL KNEE IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL KNEE IMPLANT MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL KNEE IMPLANT MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL KNEE IMPLANT MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL KNEE IMPLANT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL KNEE IMPLANT MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL KNEE IMPLANT MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL KNEE IMPLANT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL KNEE IMPLANT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL KNEE IMPLANT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL KNEE IMPLANT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL KNEE IMPLANT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL KNEE IMPLANT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL KNEE IMPLANT MARKET SIZE, BY EXCLUSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL KNEE IMPLANT MARKET SIZE, BY EXCLUSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL KNEE IMPLANT MARKET SIZE, BY EXCLUSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL KNEE IMPLANT MARKET SIZE, BY NONEXCLUSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL KNEE IMPLANT MARKET SIZE, BY NONEXCLUSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL KNEE IMPLANT MARKET SIZE, BY NONEXCLUSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL KNEE IMPLANT MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL KNEE IMPLANT MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL KNEE IMPLANT MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL KNEE IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS KNEE IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL KNEE IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. GCC KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 234. GCC KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. GCC KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 236. GCC KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 237. GCC KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. GCC KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 239. GCC KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. GCC KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 241. GCC KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GCC KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 243. GCC KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. GCC KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 271. G7 KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 272. G7 KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 273. G7 KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. G7 KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 275. G7 KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 276. G7 KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. G7 KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 278. G7 KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 279. G7 KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 280. G7 KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. G7 KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 282. G7 KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. G7 KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 284. NATO KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. NATO KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 286. NATO KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 287. NATO KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 288. NATO KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 289. NATO KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 290. NATO KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 291. NATO KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 292. NATO KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 293. NATO KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. NATO KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 295. NATO KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. NATO KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 297. GLOBAL KNEE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES KNEE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 311. CHINA KNEE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 312. CHINA KNEE IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 313. CHINA KNEE IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA KNEE IMPLANT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA KNEE IMPLANT MARKET SIZE, BY CRUCIATE RETAINING, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA KNEE IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA KNEE IMPLANT MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA KNEE IMPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA KNEE IMPLANT MARKET SIZE, BY CONSTRAINT LEVEL, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA KNEE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA KNEE IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA KNEE IMPLANT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)